vs

Side-by-side financial comparison of GENERATION INCOME PROPERTIES, INC. (GIPR) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

GENERATION INCOME PROPERTIES, INC. is the larger business by last-quarter revenue ($2.5M vs $1.8M, roughly 1.4× INVO Fertility, Inc.). GENERATION INCOME PROPERTIES, INC. runs the higher net margin — -14.6% vs -150.5%, a 135.9% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -8.0%). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs 0.5%).

Emaar Properties is an Emirati real estate development company located in the United Arab Emirates. The two largest shareholders are Dubai ruler Mohammed bin Rashid Al Maktoum and the UAE's sovereign wealth fund Investment Corporation of Dubai.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

GIPR vs IVF — Head-to-Head

Bigger by revenue
GIPR
GIPR
1.4× larger
GIPR
$2.5M
$1.8M
IVF
Growing faster (revenue YoY)
IVF
IVF
+30.6% gap
IVF
22.6%
-8.0%
GIPR
Higher net margin
GIPR
GIPR
135.9% more per $
GIPR
-14.6%
-150.5%
IVF
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
0.5%
GIPR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
GIPR
GIPR
IVF
IVF
Revenue
$2.5M
$1.8M
Net Profit
$-359.5K
$-2.6M
Gross Margin
Operating Margin
-58.6%
-93.1%
Net Margin
-14.6%
-150.5%
Revenue YoY
-8.0%
22.6%
Net Profit YoY
-22.7%
-62.2%
EPS (diluted)
$-0.17
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GIPR
GIPR
IVF
IVF
Q4 25
$2.5M
Q3 25
$2.5M
$1.8M
Q2 25
$2.4M
$1.9M
Q1 25
$2.4M
$1.6M
Q4 24
$2.7M
$1.7M
Q3 24
$2.4M
$1.4M
Q2 24
$2.3M
$1.8M
Q1 24
$2.4M
$1.6M
Net Profit
GIPR
GIPR
IVF
IVF
Q4 25
$-359.5K
Q3 25
$-2.8M
$-2.6M
Q2 25
$-4.4M
$-5.3M
Q1 25
$-2.7M
$-17.4M
Q4 24
$-292.9K
$-3.6M
Q3 24
$-3.0M
$-1.6M
Q2 24
$-2.3M
$-2.2M
Q1 24
$-2.8M
$-1.6M
Gross Margin
GIPR
GIPR
IVF
IVF
Q4 25
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
GIPR
GIPR
IVF
IVF
Q4 25
-58.6%
Q3 25
-68.8%
-93.1%
Q2 25
-97.6%
-160.4%
Q1 25
-62.0%
-1042.1%
Q4 24
-40.9%
-202.0%
Q3 24
-57.1%
-90.7%
Q2 24
-65.1%
-100.9%
Q1 24
-49.3%
-95.7%
Net Margin
GIPR
GIPR
IVF
IVF
Q4 25
-14.6%
Q3 25
-114.4%
-150.5%
Q2 25
-181.8%
-283.6%
Q1 25
-114.7%
-1060.1%
Q4 24
-11.0%
-211.3%
Q3 24
-123.7%
-113.8%
Q2 24
-100.1%
-122.2%
Q1 24
-116.1%
-101.3%
EPS (diluted)
GIPR
GIPR
IVF
IVF
Q4 25
$-0.17
Q3 25
$-0.52
$-0.77
Q2 25
$-0.81
$-13.30
Q1 25
$-0.50
$-12.53
Q4 24
$0.00
$14.86
Q3 24
$-0.55
$-15.11
Q2 24
$-0.42
$-22.39
Q1 24
$-0.67
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GIPR
GIPR
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$6.2M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$-4.2M
$5.8M
Total Assets
$97.3M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GIPR
GIPR
IVF
IVF
Q4 25
$6.2M
Q3 25
$247.3K
Q2 25
$356.1K
Q1 25
$630.6K
Q4 24
$612.9K
Q3 24
$1.5M
Q2 24
$2.6M
Q1 24
$1.7M
Total Debt
GIPR
GIPR
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GIPR
GIPR
IVF
IVF
Q4 25
$-4.2M
Q3 25
$-3.9M
$5.8M
Q2 25
$-1.4M
$2.6M
Q1 25
$3.1M
$3.3M
Q4 24
$5.8M
$12.7M
Q3 24
$6.2M
$-23.3K
Q2 24
$9.1M
$1.4M
Q1 24
$11.9M
$10.2K
Total Assets
GIPR
GIPR
IVF
IVF
Q4 25
$97.3M
Q3 25
$103.4M
$18.8M
Q2 25
$105.0M
$19.3M
Q1 25
$116.7M
$31.7M
Q4 24
$106.6M
$46.4M
Q3 24
$108.0M
$17.0M
Q2 24
$104.5M
$17.8M
Q1 24
$104.6M
$17.3M
Debt / Equity
GIPR
GIPR
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GIPR
GIPR
IVF
IVF
Operating Cash FlowLast quarter
$929.5K
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.0%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GIPR
GIPR
IVF
IVF
Q4 25
$929.5K
Q3 25
$935.4K
$-1.8M
Q2 25
$-1.2M
$-1.7M
Q1 25
$718.2K
$-3.5M
Q4 24
$1.0M
$-617.4K
Q3 24
$556.9K
$-640.8K
Q2 24
$200.6K
$-1.5M
Q1 24
$26.0K
$-260.6K
Free Cash Flow
GIPR
GIPR
IVF
IVF
Q4 25
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-4.8M
$-696.3K
Q3 24
$-5.4M
Q2 24
$-1.5M
Q1 24
$-310.3K
FCF Margin
GIPR
GIPR
IVF
IVF
Q4 25
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-177.9%
-40.6%
Q3 24
-225.1%
Q2 24
-82.3%
Q1 24
-19.7%
Capex Intensity
GIPR
GIPR
IVF
IVF
Q4 25
0.0%
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
216.2%
4.6%
Q3 24
248.3%
0.0%
Q2 24
3.0%
Q1 24
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons